GLP-3 (RTA)

GLP-3 (RTA) Research Peptide

This GLP-3 (RTA) formulation is designed to support research protocols that require higher cumulative dosing capacity or extended treatment durations across multiple study subjects without supply interruptions. The larger quantity format accommodates both acute challenge studies and chronic exposure designs spanning several weeks or months of continuous investigation.

Interest in triple-agonist research has grown considerably following publication of foundational mechanism-of-action studies demonstrating superior metabolic outcomes. GLP-3 (RTA) simultaneously engages three critical metabolic pathways, generating integrated biological responses that are observable across comprehensive phenotyping study designs. This quantity enables factorial dosing designs across multiple animal subjects with adequate statistical replication and sufficient power to detect meaningful treatment effects.

Recent pharmacology literature, including work published in Nature Metabolism (2023), underscores the value of mapping dose-response relationships across a range of metabolic endpoints — including glucose utilization rates, insulin secretion kinetics, hepatic lipid metabolism, intestinal glucose absorption, and energy homeostasis parameters. Larger supply volumes support these comprehensive investigations by reducing technical constraints associated with reconstitution timing and peptide degradation between repeated preparations, thereby minimizing batch variation artifacts.

Stability data confirms that reconstituted solutions retain measurable biological activity for 48 hours when held at 4°C, with detectable decline occurring beyond that window. The lyophilized form preserves baseline activity indefinitely under appropriate storage conditions, offering flexibility for varied experimental timelines, multi-site collaborative protocols, and serial sampling designs across extended study periods.

GLP-3 (RTA) — Product Specifications

• Form: Lyophilized powder

• Reconstitution: Bacteriostatic water or normal saline (standard volumes of 10–15mL)

• Storage: 2–8°C (solid state); 48-hour stability window post-reconstitution at 4°C

• Purity: ≥98%, HPLC verified

• Bacterial Endotoxin: <5 EU/mL (LAL tested)

• Osmolality: 280–300 mOsm/kg (physiological range)

Research Use Only

Intended exclusively for licensed laboratory research. Not approved for human use, therapeutic trials, or in vivo studies conducted outside of regulated institutional oversight protocols.